Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

418398

registered interest
date	11/09/2015
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Financial Services: Compensation
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what discussions he has had with his EU counterparts and the European Commission on retaining the level of UK bank deposit guarantees at £85,000; and what estimate he has made of the level of funds set aside for such guarantees in (a) 2015 and (b) 2016.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	10016
answer	answer is ministerial correction date of answer 16/09/2015 answer text <p>As with any new EU legislation, HM Treasury engaged in discussions with the European Commission and other EU member states during the negotiation of the Deposit Guarantee Schemes Directive, and following its adoption in order to manage the transposition effectively. HM Treasury laid a statutory instrument to ensure that UK depositors would not be exposed to a sudden reduction in the level of protection to which they are entitled from the Financial Services Compensation Scheme (FSCS).</p><p> </p><p> </p><p> </p><p>FSCS compensation is funded by levies on regulated financial services firms, within a limit which is set by the Financial Conduct Authority and Prudential Regulation Authority.</p><p> </p> answering member constituency West Worcestershire answering member printed Harriett Baldwin question first answered 16/09/2015 16:44:10 answering member 4107 label Biography information for Dame Harriett Baldwin
tabling member	4140 label Biography information for Mr David Nuttall

418445

registered interest
date	11/09/2015
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, pursuant to the Answer of 3 July 2015 to Question 4126, how many times the procedure provided for in the Council Decision of 29 March 1994 have been invoked; what the concerns of the member states that invoked the procedure were in each such case; and how those concerns were met in the final decision taken in each such case.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	10013
answer	answer is ministerial correction date of answer 18/09/2015 answer text <p>The Council Decision of 29 March 1994, also known as the Ioannina Compromise, was superseded by the Treaty of Nice, and subsequently by the Treaty of Lisbon in 2007. From 2014, a new version of the Ioannina Compromise took effect. This allows a group of Member States short of a blocking minority to request a deferral of decisions they do not agree with, within a reasonable timeframe. The Government does not maintain a central record of when the provision has been invoked or for what reason.</p> answering member constituency Aylesbury answering member printed Mr David Lidington question first answered 18/09/2015 12:25:47 answering member 15 label Biography information for Sir David Lidington
tabling member	4140 label Biography information for Mr David Nuttall

418454

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions his Department has had with health bodies on ensuring timely treatment for sufferers of Ehlers-Danlos syndrome.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9988
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9987 9989 question first answered 21/09/2015 10:00:16 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall

418457

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average length of time is between the diagnosis of a patient with Ehlers-Danlos syndrome and referral for specialist treatment in (a) London and (b) Greater Manchester.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9989
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9987 9988 question first answered 21/09/2015 10:00:17 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall

418461

registered interest
date	11/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Ehlers-Danlos Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of patient outcomes of those diagnosed with Ehlers-Danlos syndrome in (a) London and (b) Greater Manchester.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9987
answer	answer is ministerial correction date of answer 21/09/2015 answer text <p>Information on patient outcomes of those diagnosed with Ehlers-Danlos Syndrome (EDS) in London and Greater Manchester is not held centrally by the Department. EDS falls within specialised services managed by NHS England.</p><p> </p><p> </p><p> </p><p>The UK Strategy for Rare Diseases sets out the Government’s on-going commitment to ensuring that patients with rare diseases, including EDS, have access to high quality services. The Strategy is discussed regularly with health bodies including NHS England. The national specialised service for atypical or complex cases aims to reduce times to diagnosis and reduce the number of hospital appointments required to achieve a specific diagnosis.</p><p> </p><p> </p><p> </p><p>Information about the average time from diagnosis to referral for specialist treatment is not available centrally. Patients suspected of having EDS may be assessed and diagnosed in a wide range of settings. These include United Kingdom regional clinical genetics clinics and various other secondary and tertiary speciality clinics.</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 9988 9989 question first answered 21/09/2015 10:00:13 answering member 4020 label Biography information for George Freeman
tabling member	4140 label Biography information for Mr David Nuttall

418470

registered interest
date	11/09/2015
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Immigration: EU Nationals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, what estimate he has made of the number of non-UK EU citizens residing in the UK who were previously refugees granted citizenship in another EU member state in the most recent period for which figures are available.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	10012
answer	answer is ministerial correction date of answer 15/09/2015 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Reading East answering member printed Mr Rob Wilson question first answered 15/09/2015 16:18:11 answering member 1556 label Biography information for Mr Rob Wilson attachment 1 file name PQ10012.pdf title UKSA Letter to Member - Refugee Citizenships
tabling member	4140 label Biography information for Mr David Nuttall

418256

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Aspartame
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research his Department has undertaken or commissioned on possible links between aspartame and (a) aggressive behaviour, (b) depression, (c) anxiety and (d) Graves' Disease.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9849
answer	answer is ministerial correction date of answer 18/09/2015 answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9850 9861 9862 question first answered 18/09/2015 09:47:50 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

418257

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Artificial Sweeteners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research and discussions his Department has had with the food industry and relevant professional bodies over the safety of aspartame and other artificial sweeteners.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9850
answer	answer is ministerial correction date of answer 18/09/2015 answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9849 9861 9862 question first answered 18/09/2015 09:47:50 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

418258

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Artificial Sweeteners
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions his Department has had with the food industry and relevant professional bodies on the safety of (a) aspartame and (b) other artificial sweeteners.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9861
answer	answer is ministerial correction date of answer 18/09/2015 answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9849 9850 9862 question first answered 18/09/2015 09:47:50 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall

418259

registered interest
date	10/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Aspartame
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment his Department has made of the safety of aspartame in food and other consumable products.
tabling member constituency	Bury North
tabling member printed	Mr David Nuttall
uin	9862
answer	answer is ministerial correction date of answer 18/09/2015 answer text <p>We are advised by the Food Standards Agency (FSA) that all food additives, including sweeteners, are only permitted after a robust evaluation of their safety. The foods in which the sweeteners can be used and their conditions of use are regulated under harmonised European Union legislation on food additives.</p><p> </p><p> </p><p> </p><p>The results of an FSA funded study on aspartame were published in March 2015. The study was designed to examine whether self-diagnosed individuals exhibit any reactions which can be observed in a clinical setting, after consuming bars that do or do not contain aspartame. Participants showed no difference in their response whether they contained aspartame or not.</p><p> </p><p> </p><p> </p><p>As part of its systematic re-evaluation of all food additives, the European Food Safety Authority (EFSA) re-evaluated the safety of aspartame and concluded in December 2013 that 'aspartame and its breakdown products are safe for human consumption at current levels of exposure'. In undertaking their re-evaluation EFSA had access to all available, relevant scientific studies and data on aspartame.</p><p> </p><p> </p><p> </p><p>Officials in the FSA have regular discussions with industry, and other interested parties, on a range of issues. Since EFSA reaffirmed the safety on the current use of aspartame, these have not routinely included discussions on aspartame or other sweeteners.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 9849 9850 9861 question first answered 18/09/2015 09:47:50 answering member 3918 label Biography information for Jane Ellison
tabling member	4140 label Biography information for Mr David Nuttall